Tacrolimus is effective for neuromyelitis optica spectrum disorders with or without anti-AQP4 antibody

Conclusion: Combined use of TAC with PSL clearly suppressed relapse of both anti-AQP4 antibody-positive and -negative NMOSD. In the anti-AQP4 antibody-positive group, both PSL dose and EDSS score decreased compared with the dose at the start of the study.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research